US Patent Issued to OSR Holdings on July 14 for "Activin/BMP7 chimeras: super-active SAB704 and SAB715, and their respective nogginsensitized variants, NAB704 and NAB715; and NAB204" (South Korean Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,876, issued on July 14, was assigned to OSR Holdings Co. Ltd. (Gyeonggi-do, South Korea).

"Activin/BMP7 chimeras: super-active SAB704 and SAB715, and their respective nogginsensitized variants, NAB704 and NAB715; and NAB204" was invented by Seunghyon Choe (Incheon, South Korea) and So-Mi Yoon (Incheon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to chimeric polypeptide having TGF-beta activity, nucleic acids encoding the polypeptides, and host cells for producing the polypeptides with improved or novel biological and therapeutic properties."

The patent was filed on Nov. 13, 2019, under Application No. 1...